Our Pipeline

We are developing novel protein therapeutics targeting inflammatory and degenerative diseases. Our Pipeline below shows the current stage of our programmes.

Programme
Discovery
Preclinical
Clinical (Early)
Clinical (Late)

Opthamology

Musculoskeletal

Programme

LB001

Dry Eye Disease

LB001

Dry Eye
Disease

LB004

Wet AMD

LB004

Wet
AMD

LB002

Osteoarthritis

LB002

Osteo-
arthritis

LB003

Osteoarthritis

LB003

Osteo-
arthritis

Opthamology

Musculoskeletal

Programme
Discovery
Preclinical
Clinical (Early)
Clinical (Late)

LB001

Dry Eye Disease

LB004

Wet AMD

LB002

Osteoarthritis

LB003

Osteoarthritis